B

Biocartis Group NV
BCART

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€27.24M
EV
-
Shares Outstanding
93.92M
Beta
1.26

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2023E
-
P/Revenue 2023E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Biocartis Group NV

gainify

B

Biocartis Group NV

BCART

Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. Its proprietary molecular diagnostics Idylla platform is a...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Moody, Roger

Employees

526

IPO Date

2015-04-27

Headquarters

Generaal de Wittelaan 11 B, Mechelen, Antwerp, 2800, Belgium

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved